Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs370443017 | chr13:54163256 | G/GT | 2.87E-5 | 171 | 25.87 | 19.72 | 21.23 | KM Plot |
PCPG | rs370603588 | chr13:64109146 | ATT/A | 6.87E-8 | 178 | 25.87 | 22.63 | 18.13 | KM Plot |
PCPG | rs370821570 | chr11:18144490 | G/A | 3.76E-5 | 175 | 27.27 | 24.82 | 6.7 | KM Plot |
PCPG | rs370907757 | chr10:131941048 | CAATCTTCCAGTACCGCCTAGGACCCCTT/C | 0 | 175 | 25.4 | 25.97 | 3.17 | KM Plot |
PCPG | rs370964375 | chr5:50603965 | T/C | 8.19E-5 | 173 | 25.17 | 24.62 | 31.35 | KM Plot |
PCPG | rs371236 | chr17:3241329 | A/G | 0.000207 | 173 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs371263878 | chr12:56754371 | TTA/T | 0.000286 | 170 | 25.67 | 30.93 | 4.23 | KM Plot |
PCPG | rs371839565 | chr17:1427540 | A/G | 1.39E-5 | 175 | 24.62 | 26.73 | 25.17 | KM Plot |
PCPG | rs372371129 | chr13:37659392 | GTT/G | 0.000361 | 170 | 4.17 | 23.88 | 27.2 | KM Plot |
PCPG | rs372872191 | chr16:1773016 | GTTTGTTTTTGTT/G | 0 | 170 | 25.6 | 24.1 | 2.93 | KM Plot |
PCPG | rs372939278 | chr17:36996157 | TAC/T | 4.5E-6 | 174 | 25.17 | 36.33 | 24.52 | KM Plot |
PCPG | rs3729851 | chr8:11612842 | G/A | 7.44E-11 | 172 | 25.75 | 21.9 | 8.13 | KM Plot |
PCPG | rs373051007 | chr16:90074427 | A/C | 7.45E-9 | 177 | 25.77 | 20.37 | 6.62 | KM Plot |
PCPG | rs3731620 | chr2:24262060 | G/A | 0.000118 | 177 | 25.28 | 26.57 | 17.43 | KM Plot |
PCPG | rs3735155 | chr7:66407130 | G/T | 0.000206 | 177 | 24.7 | 28.42 | 33.17 | KM Plot |